[Dynamics of clinical, X-ray and functional data during treatment of patients with sarcoidosis].

Aim: To analyze the literature data and the results of original studies on the respiratory function in patients with sarcoidosis.

Material And Methods: The study included 1199 patients with sarcoidosis (67.8% women and 32.

[X-ray, laboratory, and functional parallels in intrathoracic sarcoidosis].

Aim: to compare respiratory function and laboratory data with the radiographic stages of intrathoracic sarcoidosis.

Subjects And Methods: Three hundred and eleven patients (70.4% for women and 29.

[Multicenter retrospective analysis of the patients with sarcoidosis with a 10 year interval in observations].

Comparison of the state of 83 patients with histologically confirmed sarcoidosis observed with a 10 year interval revealed remission in 47% of the cases. The main factors having negative effect on prognosis of the disease included extrapulmonary symptoms, the use ofcorticosteroids (at all stages, especially at stage I and in Lofgren syndrome) and antituberculosis drugs, positive TB test. Risk factors of relapses were stage II sarcoidosis, the use of systemic corticosteroids in patients with Lofgren syndrome and antituberculosis drugs, initially low FEV1/FVLC ratio and the number of lymphocytes in peripheral blood.

[Comparison of acute bronchodilator tests in patients with chronic obstructive lung disease and bronchial asthma].

Three hundred and thirty-five patients with bronchial asthma (BA) and 534 patients with chronic obstructive lung disease (COLD) were examined. Before and after tests using salbutamol, phenoterol, ipratropium bromide and a fixed combination of phenoterol and ipratropium bromide, the forced expiratory flow-volume curve was recorded in the patients on each visit (1008 and 1398 visits of patients with BA and COLD, respectively). The study was controlled open-labeled, and prospective.